Healthcare
AFM-Téléthon and FNA launch biotherapy-focused fund
Charity AFM-Téléthon and French state-backed fund-of-funds Fonds National d'Amorçage (FNA) have committed €50m to a new seed fund dedicated to biotherapy and rare diseases research.
Charterhouse enters Italian market, buys Doc Generici
Charterhouse Capital Partners has wholly acquired Italian pharmaceutical firm Doc Generici, marking the GP’s first transaction in the Italian market, according to reports.
Phagenesis expands series-B round to $17m
Phagenisis has extended its series-B funding round to reach $17m.
HealthCap, Industrifonden et al. back Oncopeptides
HealthCap, Industrifonden and other investors have taken part in a series-A financing round for Swedish medical start-up Oncopeptides AB.
Mig et al. add €9.5m to SuppreMol series-D round
Mig AG and BioMed Partners have injected an additional €9.5m into Germany-based SuppreMol alongside a number of other backers in an extension of the company’s series-D funding round.
3i reaps 2.3x on Xellia exit
3i has agreed to sell Xellia Pharmaceuticals AS, a Norwegian speciality pharmaceutical group, to Novo AS for £460m.
Merck increases MS Ventures commitment
Merck Group has topped up its strategic venture capital fund MS Ventures with an additional €60m commitment and created an investment affiliate to specifically manage the vehicle.
SEP backs €16m Mister Spex round
Scottish Equity Partners (SEP) has joined a €16m round of funding for German online optician Mister Spex.
Caixa Capital Risc leads €1.1m round for iMicroQ
Caixa Capital Risc has led a €1.1m funding round for Spanish biotech firm iMicroQ.
Cardio3 raises €19m in new funding round
Belgian biopharmaceutical company Cardio3 Biosciences has completed a funding round that saw previous investors inject €7m in new equity alongside the conversion of €12m in existing convertible loans.
Omega Funds leads $10m round for SpineVision
Omega Funds has led a $10m funding round for French medical devices provider SpineVision, which also included investments from two other new backers.
Kurma leads €17m series-B round for Stat Diagnostica
Kurma Life Sciences Partners has led a €17m series-B round for Spanish medical diagnostics company Stat Diagnostica.
Novo AS et al. round up €141m Symphogen financing
Novo AS, PKA and Danica Pension have provided Danish biopharmaceutical company Symphogen with a further €41m, rounding up a €141m funding round for the business.
Swedish GPs cash in on pharmaceutical reform
Swedish healthcare bonanza
Novartis Venture et al. in €33m series-C round for Opsona
A consortium of new and existing investors has injected €33m into Irish immunology drug development company Opsona Therapeutics as part of a series-C funding round.
LBO France's Médi-Partenaires hopes to raise €385m on high-yield market
Médi-Partenaires, a French chain of clinics backed by LBO France and Equistone, is understood to be aiming to raise €385m on the high-yield bond market.
Wellington invests €4m in €18.2m Genticel series-C
Wellington Partners has injected €4m into French vaccine developer Genticel as part of an €18.2m series-C funding round alongside existing shareholders.
BayBG joins HTGF and Bayern Kapital in €1m GME series-A
BayBG has joined existing investors High-Tech Gründerfonds (HTGF) and Bayern Kapital in a €1m series-A round for German laser and light systems provider German Medical Engineering (GME), alongside private investors.
Seventure Partners invests €2.5m in Personal MedSystems
Seventure Partners has invested in German mobile medical equipment company Personal MedSystems, alongside High-Tech Gründerfonds, as part of a €2.5m series-A financing.
EdRip and Forbion lead funding for Allecra Therapeutics
Edmond de Rothschild Investment Partners (EdRip) and Forbion Capital Partners have invested in a €15m series-A round for Swiss biotech company Allecra Therapeutics.
BGF’s Springfield Homecare Services acquires PLC
Business Growth Fund-backed Springfield Homecare Services has acquired domiciliary care business Positive Life Choices (PLC).
HTGF et al. invest €2.6m in Rodos BioTarget
High-Tech Gründerfonds (HTGF), InvestImpuls-Fonds and KfW’s ERP Start Fund have invested €2.6m of growth capital in German biotech company Rodos BioTarget, alongside private investors and family offices.
Sofinnova backs Auris Medical with CHF 47.1m
French VC Sofinnova Partners has joined US-based Sofinnova Ventures in a CHF 47.1m funding round for Auris Medical.
Lundbeckfond Ventures et al. invest in DySis Medical
Lundbeckfond Ventures has led a £7.4m fundraising round in DySis Medical Ltd, a women’s health medical devices company.